The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×

General psychiatrists are increasingly expected to be able to diagnose common neuropsychiatric disorders. Residents must now achieve milestones in neuropsychiatry and neuroscience as part of general psychiatry training (1). It is therefore altogether fitting that neuropsychiatry has been selected as the topic for this issue of Focus. Reviewed in this issue are common disorders at the interface of psychiatry and neurology, the underlying mechanisms of which are beginning to be elucidated. These conditions often present to psychiatrists, initially or eventually, as behavioral or mood changes, cognitive impairment, or psychosis.

Vassilis Koliatsos, M.D., highlights the many presentations of cognitive impairment and a clinical approach to patients with cognitive complaints (2). He conveys several clinical pearls to guide assessment and treatment of this common problem.

Thomas McAllister, M.D., presents a comprehensive overview of mild traumatic brain injury, from clinical practice to the latest research (3). The neurobehavioral sequelae that can result after mild brain injury are emphasized along with the complexities that influence outcomes.

Autoimmune limbic encephalitis has become well known as a neuropsychiatric condition that can first present to psychiatry because of its association with psychosis and with cognitive syndromes that are responsive to immune system–based treatments. Michael Zandi, Ph.D., M.R.C.P., presents a clinical approach to patients with suspected anti-NMDA receptor encephalitis, specifically with regard to assessment and differential diagnoses (4).

Sepideh Bajestan, M.D., Ph.D., and Curt LaFrance, M.D., M.P.H., outline the biological and psychosocial underpinnings of nonepileptic seizures and present practical clinical approaches to diagnosis and treatment (5). Mood disorders often co-occur with epilepsy. Jay Salpekar, M.D., highlights diagnostic considerations and treatment strategies for these comorbid disorders, with attention to temporal lobe pathophysiology, and offers pharmacological pearls for clinical practice (6).

Peter Ljubenkov, M.D., and Bruce Miller, M.D., provide Focus readers with a clinical guide to behavioral-variant frontotemporal dementia, a disorder that often presents to psychiatrists (7). Differential diagnoses, underlying genetics, and clinical pathological correlates are included.

We are extremely grateful to the authors of this clinical neuropsychiatry edition of Focus and fellow members of the American Neuropsychiatric Association for their kind collaboration. We hope you will enjoy learning from their work and using the information to strengthen your practices.

Dr. Lauterbach is a neuropsychiatrist at the Sheppard Pratt Health System, and a clinical assistant professor in the Department of Psychiatry, University of Maryland School of Medicine, Baltimore. Dr. Benjamin is professor of Psychiatry and Neurology, director of Neuropsychiatry, and vice-chair for Education in Psychiatry, University of Massachusetts Medical School, Worcester.

Dr. Benjamin and Dr. Lauterbach report joint ownership of Brain Educators, LLC, a company that publishes neuropsychiatric educational resources.

References

1 Benjamin S, Widge A, Shaw K: Neuropsychiatry and neuroscience milestones for general psychiatry trainees. Acad Psychiatry 2014; 38:275–282CrossrefGoogle Scholar

2 Koliatsos VE: A clinical approach to cognitive impairment. Focus 2016; 14:437–447LinkGoogle Scholar

3 McAllister TW: Mild traumatic brain injury. Focus 2016; 14:410–421LinkGoogle Scholar

4 Zandi MS: Autoimmune encephalitis. Focus 2016; 14:432–436LinkGoogle Scholar

5 Bajestan S, LaFrance WC: Clinical approaches to psychogenic nonepileptic seizures. Focus 2016; 14:422–431LinkGoogle Scholar

6 Salpekar J: Mood disorders in epilepsy. Focus 2016; 14:465–472LinkGoogle Scholar

7 Ljubenkov PA, Miller BL: A clinical guide to frontotemporal dementias. Focus 2016; 14:448–464LinkGoogle Scholar